Table 2 Changes in plasma levels of homocysteine, cysteine, and cysteinylglycine from baseline to week 12 in overweight men who consumed a CRD.
From: Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease
Parameter | Baseline | Week 12 | P Value (Time) |
|---|---|---|---|
Homocysteine (μmol/L) |  |  |  |
Fiber | 8.1 ± 1.2 | 8.6 ± 2.2 | > 0.05 |
Placebo | 8.1 ± 1.4 | 8.3 ± 1.5 | > 0.05 |
Cysteine (μmol/L) |  |  |  |
Fiber | 264.4 ± 34.1 | 258.9 ± 45.3 | > 0.05 |
Placebo | 269.0 ± 30.5 | 266.2 ± 40.7 | > 0.05 |
Cysteinylglycine (μmol/L) |  |  |  |
Fiber | 30.3 ± 5.1 | 29.9 ± 4.5 | > 0.05 |
Placebo | 30.9 ± 3.8 | 29.0 ± 5.5 | > 0.05 |